2026 NPPES data Oral and Maxillofacial Pathology Dentistry NPI 1578075248 BDS
Verify on CMS →

LAMA ALABDULAALY, BDS

Oral and Maxillofacial Pathology Dentistry in BOSTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
424
Medicare Part D claims · 168 beneficiaries · Oral and Maxillofacial Pathology Dentistry avg: 303
What the federal data reveals: LAMA ALABDULAALY, BDS is a Oral and Maxillofacial Pathology Dentistry ([object Object]) practicing in BOSTON, Massachusetts with a Medicare Part D prescribing footprint of 424 claims across 168 beneficiaries .

What stands out: LAMA ALABDULAALY, BDS filed 424 Medicare Part D claims in 2023 across BOSTON, Massachusetts. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

LAMA ALABDULAALY, BDS at a glance

Quality data not reported

NPI registry status

Active

Issued 11/02/2017

NPI 1578075248

Primary specialty

Oral and Maxillofacial Pathology Dentistry

Niche

690 US NPIs in this specialty

Medicare Part D claims

424 40% vs specialty avg

2023 prescription claims

Specialty avg: 303

Specialty distribution in Massachusetts

How Oral and Maxillofacial Pathology Dentistry compares to other specialties among Massachusetts providers

Massachusetts providers

Oral and Maxillofacial Pathology Dentistry share within Massachusetts

1. Oral and Maxillofacial Pathology Dentistry42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oral and Maxillofacial Pathology Dentistry share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Oral and Maxillofacial Pathology Dentistry (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oral and Maxillofacial Pathology Dentistry ABMS/AOA estimate

Est. board-certified rate (Oral and Maxillofacial Pathology Dentistry) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oral and Maxillofacial Pathology Dentistry) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LAMA ALABDULAALY, BDS is a Oral and Maxillofacial Pathology Dentistry provider practicing in BOSTON, Massachusetts, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: BDS. NPI: 1578075248. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

LAMA ALABDULAALY, BDS appears in the CMS NPPES registry as a Oral and Maxillofacial Pathology Dentistry provider holding BDS credentials at 45 FRANCIS ST, BOSTON, MA, 02115, with a listed phone of (617) 608-8412. NPI 1578075248 was issued on 11/02/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ALABDULAALY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 424 prescription claims written by this provider, covering 168 Medicare beneficiaries and totaling roughly $20K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oral and Maxillofacial Pathology Dentistry is a narrow specialty nationwide, with 690 enrolled providers across 48 states and an average of 303 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

45 FRANCIS ST
BOSTON, MA 02115

Provider Details

NPI 1578075248
Specialty Oral and Maxillofacial Pathology Dentistry
Credentials BDS
Gender Female
NPI Issued 11/02/2017

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to LAMA ALABDULAALY, BDS. To verify LAMA ALABDULAALY, BDS's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

424
Total Claims
$20K
Total Drug Cost
168
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
533
Total Day Supply
14,346
Generic Drug Cost
$20K
Antibiotic Claims
27

Patient Demographics

Average Patient Age
72.7 years
Avg HCC Risk Score
1.97
Gender Split
71% female / 29% male
Age Distribution
<65: 21, 65-74: 78, 75-84: 55, 85+: 14

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Dexamethasone
82
Chlorhexidine Gluconate
59
Nystatin
34
Clonazepam
29
Pilocarpine Hcl
26
Fluconazole
21
Clobetasol Propionate
20
Cevimeline Hcl
17
Gabapentin
17
Fluocinonide
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oral and Maxillofacial Pathology Dentistry Overview

How LAMA ALABDULAALY, BDS fits within the Oral and Maxillofacial Pathology Dentistry landscape nationally.

690
Oral and Maxillofacial Pathology Dentistry Providers in US
48
States with Oral and Maxillofacial Pathology Dentistry
303
Avg Claims per Provider

LAMA ALABDULAALY, BDS's 424 claims are above the specialty average of 303.

Nearby Oral and Maxillofacial Pathology Dentistry Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as ALABDULAALY.

Compare Oral and Maxillofacial Pathology Dentistry nationally: see state-by-state distribution →

Frequently Asked Questions

What is LAMA ALABDULAALY, BDS's specialty?
LAMA ALABDULAALY, BDS specializes in Oral and Maxillofacial Pathology Dentistry and practices in BOSTON, Massachusetts. Credentials: BDS.
How much does LAMA ALABDULAALY, BDS prescribe under Medicare Part D?
In 2023, LAMA ALABDULAALY, BDS wrote 424 Medicare Part D claims totaling $20K in drug costs for 168 beneficiaries.
Where is LAMA ALABDULAALY, BDS located?
LAMA ALABDULAALY, BDS is located at 45 FRANCIS ST, BOSTON, MA, 02115. Phone: (617) 608-8412.
What is LAMA ALABDULAALY, BDS's NPI number?
LAMA ALABDULAALY, BDS's National Provider Identifier (NPI) is 1578075248, issued on 11/02/2017.
How many Oral and Maxillofacial Pathology Dentistry providers are there in the US?
There are 690 Oral and Maxillofacial Pathology Dentistry providers across 48 states in the US. The average Oral and Maxillofacial Pathology Dentistry provider writes 303 Medicare Part D claims per year.
What drugs does LAMA ALABDULAALY, BDS prescribe most often?
Based on 2023 Medicare Part D data, LAMA ALABDULAALY, BDS's most frequently prescribed drugs include Dexamethasone, Chlorhexidine Gluconate, Nystatin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LAMA ALABDULAALY, BDS accept Medicare?
LAMA ALABDULAALY, BDS appears in CMS Medicare data with 424 Part D claims and 168 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LAMA ALABDULAALY, BDS's credentials?
LAMA ALABDULAALY, BDS's NPI is 1578075248 with credentials BDS. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology